Sign in to edit your profile (add interests, mentoring, photo, etc.)
    Keywords
    Last Name
    Institution

    Marc Fisher MD

    TitleProfessor Emeritus
    InstitutionUniversity of Massachusetts Medical School
    DepartmentNeurology
    AddressUMass Memorial Medical Center
    108 Belmont Street
    Worcester MA 01605
    Phone508-334-6641
      Other Positions
      InstitutionUMMS - School of Medicine
      DepartmentRadiology

        Bibliographic 
        selected publications
        List All   |   Timeline
        1. Fisher M. Ensuring the future of clinical and basic stroke research. Stroke. 2014 Aug; 45(8):2493-6.
          View in: PubMed
        2. Saposnik G, Ovbiagele B, Raptis S, Fisher M, Johnston SC. Effect of english proficiency and research funding on acceptance of submitted articles to stroke journal. Stroke. 2014 Jun; 45(6):1862-8.
          View in: PubMed
        3. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, Johnston SC, Kasner SE, Kittner SJ, Mitchell PH, Rich MW, Richardson D, Schwamm LH, Wilson JA. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2014 Jul; 45(7):2160-236.
          View in: PubMed
        4. Moonis M, Srivastava P, Selim M, Fisher M. Advances and potential new treatments in stroke management. Stroke Res Treat. 2014; 2014:120384.
          View in: PubMed
        5. Sikoglu EM, Heffernan ME, Tam K, Sicard KM, Bratane BT, Quan M, Fisher M, King JA. Enhancement in cognitive function recovery by granulocyte-colony stimulating factor in a rodent model of traumatic brain injury. Behav Brain Res. 2014 Feb 1; 259:354-6.
          View in: PubMed
        6. Fisher M. Acute ischemic stroke therapy: current status and future directions. Expert Rev Cardiovasc Ther. 2013 Sep; 11(9):1097-9.
          View in: PubMed
        7. Fisher M. The spectrum of translational stroke research. Neurol Res. 2013 Jun; 35(5):443-7.
          View in: PubMed
        8. Landis S, Fisher M. Why the United States needs a network for stroke clinical trials. Stroke. 2013 May; 44(5):1217-8.
          View in: PubMed
        9. Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW, Crystal RG, Darnell RB, Ferrante RJ, Fillit H, Finkelstein R, Fisher M, Gendelman HE, Golub RM, Goudreau JL, Gross RA, Gubitz AK, Hesterlee SE, Howells DW, Huguenard J, Kelner K, Koroshetz W, Krainc D, Lazic SE, Levine MS, Macleod MR, McCall JM, Moxley RT, Narasimhan K, Noble LJ, Perrin S, Porter JD, Steward O, Unger E, Utz U, Silberberg SD. A call for transparent reporting to optimize the predictive value of preclinical research. Nature. 2012 Oct 11; 490(7419):187-91.
          View in: PubMed
        10. Fisher M. Endovascular acute ischemic stroke therapy: applying basic science to clinical decisions. Neurology. 2012 Sep 25; 79(13 Suppl 1):S42-3.
          View in: PubMed
        11. Fisher M, Bastan B. Identifying and utilizing the ischemic penumbra. Neurology. 2012 Sep 25; 79(13 Suppl 1):S79-85.
          View in: PubMed
        12. Tao WD, Liu M, Fisher M, Wang DR, Li J, Furie KL, Hao ZL, Lin S, Zhang CF, Zeng QT, Wu B. Posterior versus anterior circulation infarction: how different are the neurological deficits? Stroke. 2012 Aug; 43(8):2060-5.
          View in: PubMed
        13. Fisher M, Moonis M. Neuroprotective effects of statins: evidence from preclinical and clinical studies. Curr Treat Options Cardiovasc Med. 2012 Jun; 14(3):252-9.
          View in: PubMed
        14. Dirnagl U, Fisher M. REPRINT: International, multicenter randomized preclinical trials in translational stroke research: it is time to act. Stroke. 2012 Jun; 43(6):1453-4.
          View in: PubMed
        15. Fisher M, Bråtane BT. Imaging of experimental stroke models. Transl Stroke Res. 2012 Mar; 3(1):16-21.
          View in: PubMed
        16. Bråtane BT, Cui H, Cook DJ, Bouley J, Tymianski M, Fisher M. Neuroprotection by freezing ischemic penumbra evolution without cerebral blood flow augmentation with a postsynaptic density-95 protein inhibitor. Stroke. 2011 Nov; 42(11):3265-70.
          View in: PubMed
        17. Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox KM, Hennerici MG, Mattle HP, Rothwell PM, de Cordoüe A, Fratacci MD. Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Lancet. 2011 Jun 11; 377(9782):2013-22.
          View in: PubMed
        18. Shuaib A, Bornstein NM, Diener HC, Dillon W, Fisher M, Hammer MD, Molina CA, Rutledge JN, Saver JL, Schellinger PD, Shownkeen H. Partial aortic occlusion for cerebral perfusion augmentation: safety and efficacy of NeuroFlo in Acute Ischemic Stroke trial. Stroke. 2011 Jun; 42(6):1680-90.
          View in: PubMed
        19. Fisher M, Loscalzo J. The perils of combination antithrombotic therapy and potential resolutions. Stroke. 2011 Feb; 42(2):278-81.
          View in: PubMed
        20. Fisher M. New approaches to neuroprotective drug development. Stroke. 2011 Jan; 42(1 Suppl):S24-7.
          View in: PubMed
        21. Morris JG, Singh S, Fisher M. Testing for inherited thrombophilias in arterial stroke: can it cause more harm than good? Stroke. 2010 Dec; 41(12):2985-90.
          View in: PubMed
        22. Schäbitz WR, Laage R, Vogt G, Koch W, Kollmar R, Schwab S, Schneider D, Hamann GF, Rosenkranz M, Veltkamp R, Fiebach JB, Hacke W, Grotta JC, Fisher M, Schneider A. AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. Stroke. 2010 Nov; 41(11):2545-51.
          View in: PubMed
        23. Henninger N, Kumar R, Fisher M. Acute ischemic stroke therapy. Expert Rev Cardiovasc Ther. 2010 Oct; 8(10):1389-98.
          View in: PubMed
        24. Zhou X, Sun Y, Mazzanti M, Henninger N, Mansour J, Fisher M, Albert M. MRI of stroke using hyperpolarized 129Xe. NMR Biomed. 2011 Feb; 24(2):170-5.
          View in: PubMed
        25. El Khoury R, Fisher M, Savitz SI. Current practice versus willingness to enroll in clinical trials: paradox among vascular neurologists about treatment for acute ischemic stroke. Stroke. 2010 Sep; 41(9):2038-43.
          View in: PubMed
        26. Hachinski V, Donnan GA, Gorelick PB, Hacke W, Cramer SC, Kaste M, Fisher M, Brainin M, Buchan AM, Lo EH, Skolnick BE, Furie KL, Hankey GJ, Kivipelto M, Morris J, Rothwell PM, Sacco RL, Smith SC, Wang Y, Bryer A, Ford GA, Iadecola C, Martins SC, Saver J, Skvortsova V, Bayley M, Bednar MM, Duncan P, Enney L, Finklestein S, Jones TA, Kalra L, Kleim J, Nitkin R, Teasell R, Weiller C, Desai B, Goldberg MP, Heiss WD, Saarelma O, Schwamm LH, Shinohara Y, Trivedi B, Wahlgren N, Wong LK, Hakim A, Norrving B, Prudhomme S, Bornstein NM, Davis SM, Goldstein LB, Leys D, Tuomilehto J. Stroke: working toward a prioritized world agenda. Stroke. 2010 Jun; 41(6):1084-99.
          View in: PubMed
        27. Hachinski V, Donnan GA, Gorelick PB, Hacke W, Cramer SC, Kaste M, Fisher M, Brainin M, Buchan AM, Lo EH, Skolnick BE, Furie KL, Hankey GJ, Kivipelto M, Morris J, Rothwell PM, Sacco RL, Smith SC, Wang Y, Bryer A, Ford GA, Iadecola C, Martins SC, Saver J, Skvortsova V, Bayley M, Bednar MM, Duncan P, Enney L, Finklestein S, Jones TA, Kalra L, Kleim J, Nitkin R, Teasell R, Weiller C, Desai B, Goldberg MP, Heiss WD, Saarelma O, Schwamm LH, Shinohara Y, Trivedi B, Wahlgren N, Wong LK, Hakim A, Norrving B, Prudhomme S, Bornstein NM, Davis SM, Goldstein LB, Leys D, Tuomilehto J. Stroke: working toward a prioritized world agenda. Cerebrovasc Dis. 2010; 30(2):127-47.
          View in: PubMed
        28. Bråtane BT, Walvick RP, Corot C, Lancelot E, Fisher M. Characterization of gadolinium-based dynamic susceptibility contrast perfusion measurements in permanent and transient MCAO models with volumetric based validation by CASL. J Cereb Blood Flow Metab. 2010 Feb; 30(2):336-42.
          View in: PubMed
        29. Bråtane BT, Bouley J, Schneider A, Bastan B, Henninger N, Fisher M. Granulocyte-colony stimulating factor delays PWI/DWI mismatch evolution and reduces final infarct volume in permanent-suture and embolic focal cerebral ischemia models in the rat. Stroke. 2009 Sep; 40(9):3102-6.
          View in: PubMed
        30. Henninger N, Chowdhury N, Fisher M, Moonis M. Use of telemedicine to increase thrombolysis and advance care in acute ischemic stroke. Cerebrovasc Dis. 2009; 27 Suppl 4:9-14.
          View in: PubMed
        31. Morris JG, Duffis EJ, Fisher M. Cardiac workup of ischemic stroke: can we improve our diagnostic yield? Stroke. 2009 Aug; 40(8):2893-8.
          View in: PubMed
        32. Fisher M. Does the combination of warfarin and aspirin have a place in secondary stroke prevention? No. Stroke. 2009 May; 40(5):1944-5.
          View in: PubMed
        33. Sicard KM, Fisher M. Emerging drugs for acute ischemic stroke. Expert Opin Emerg Drugs. 2009 Mar; 14(1):33-42.
          View in: PubMed
        34. Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, Lo EH. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke. 2009 Jun; 40(6):2244-50.
          View in: PubMed
        35. Macleod MR, Fisher M, O'Collins V, Sena ES, Dirnagl U, Bath PM, Buchan A, van der Worp HB, Traystman RJ, Minematsu K, Donnan GA, Howells DW. Reprint: Good laboratory practice: preventing introduction of bias at the bench. Int J Stroke. 2009 Feb; 4(1):3-5.
          View in: PubMed
        36. Philip M, Benatar M, Fisher M, Savitz SI. Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials. Stroke. 2009 Feb; 40(2):577-81.
          View in: PubMed
        37. Henninger N, Bouley J, Bråtane BT, Bastan B, Shea M, Fisher M. Laser Doppler flowmetry predicts occlusion but not tPA-mediated reperfusion success after rat embolic stroke. Exp Neurol. 2009 Feb; 215(2):290-7.
          View in: PubMed
        38. Macleod MR, Fisher M, O'Collins V, Sena ES, Dirnagl U, Bath PM, Buchan A, Buchan A, van der Worp HB, Traystman RJ, Minematsu K, Donnan GA, Howells DW. Reprint: Good laboratory practice: preventing introduction of bias at the bench. J Cereb Blood Flow Metab. 2009 Feb; 29(2):221-3.
          View in: PubMed
        39. Henninger N, Bratane BT, Bastan B, Bouley J, Fisher M. Normobaric hyperoxia and delayed tPA treatment in a rat embolic stroke model. J Cereb Blood Flow Metab. 2009 Jan; 29(1):119-29.
          View in: PubMed
        40. Fisher M, Bastan B. Treating acute ischemic stroke. Curr Opin Drug Discov Devel. 2008 Sep; 11(5):626-32.
          View in: PubMed
        41. Savitz SI, Benatar M, Saver JL, Fisher M. Outcome analysis in clinical trial design for acute stroke: physicians' attitudes and choices. Cerebrovasc Dis. 2008; 26(2):156-62.
          View in: PubMed
        42. Fisher M. Stroke and TIA: epidemiology, risk factors, and the need for early intervention. Am J Manag Care. 2008 Jun; 14(6 Suppl 2):S204-11.
          View in: PubMed
        43. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008 May 10; 371(9624):1612-23.
          View in: PubMed
        44. Wintermark M, Albers GW, Alexandrov AV, Alger JR, Bammer R, Baron JC, Davis S, Demaerschalk BM, Derdeyn CP, Donnan GA, Eastwood JD, Fiebach JB, Fisher M, Furie KL, Goldmakher GV, Hacke W, Kidwell CS, Kloska SP, Köhrmann M, Koroshetz W, Lee TY, Lees KR, Lev MH, Liebeskind DS, Ostergaard L, Powers WJ, Provenzale J, Schellinger P, Silbergleit R, Sorensen AG, Wardlaw J, Wu O, Warach S. Acute stroke imaging research roadmap. Stroke. 2008 May; 39(5):1621-8.
          View in: PubMed
        45. Langley B, D'Annibale MA, Suh K, Ayoub I, Tolhurst A, Bastan B, Yang L, Ko B, Fisher M, Cho S, Beal MF, Ratan RR. Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1/cip1) in cell cycle-independent neuroprotection. J Neurosci. 2008 Jan 2; 28(1):163-76.
          View in: PubMed
        46. Savitz SI, Fisher M. NXY-059 for the treatment of stroke. N Engl J Med. 2007 Nov 22; 357(21):2198; author reply 2198-9.
          View in: PubMed
        47. Henninger N, Sicard KM, Li Z, Kulkarni P, Dützmann S, Urbanek C, Schwab S, Fisher M. Differential recovery of behavioral status and brain function assessed with functional magnetic resonance imaging after mild traumatic brain injury in the rat. Crit Care Med. 2007 Nov; 35(11):2607-14.
          View in: PubMed
        48. Savitz SI, Lew R, Bluhmki E, Hacke W, Fisher M. Shift analysis versus dichotomization of the modified Rankin scale outcome scores in the NINDS and ECASS-II trials. Stroke. 2007 Dec; 38(12):3205-12.
          View in: PubMed
        49. Savitz SI, Fisher M. Prophylactic neuroprotection. Curr Drug Targets. 2007 Jul; 8(7):846-9.
          View in: PubMed
        50. Tatlisumak T, Rantanen K, Fisher M. Stroke prevention: a challenging but rewarding task. Curr Drug Targets. 2007 Jul; 8(7):784-5.
          View in: PubMed
        51. Savitz SI, Fisher M. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials. Ann Neurol. 2007 May; 61(5):396-402.
          View in: PubMed
        52. Lampl Y, Zivin JA, Fisher M, Lew R, Welin L, Dahlof B, Borenstein P, Andersson B, Perez J, Caparo C, Ilic S, Oron U. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1). Stroke. 2007 Jun; 38(6):1843-9.
          View in: PubMed
        53. Ali M, Bath PM, Curram J, Davis SM, Diener HC, Donnan GA, Fisher M, Gregson BA, Grotta J, Hacke W, Hennerici MG, Hommel M, Kaste M, Marler JR, Sacco RL, Teal P, Wahlgren NG, Warach S, Weir CJ, Lees KR. The Virtual International Stroke Trials Archive. Stroke. 2007 Jun; 38(6):1905-10.
          View in: PubMed
        54. Henninger N, Sicard KM, Fisher M. Spectacular shrinking deficit: insights from multimodal magnetic resonance imaging after embolic middle cerebral artery occlusion in Sprague-Dawley rats. J Cereb Blood Flow Metab. 2007 Oct; 27(10):1756-63.
          View in: PubMed
        55. Bardutzky J, Shen Q, Henninger N, Schwab S, Duong TQ, Fisher M. Characterizing tissue fate after transient cerebral ischemia of varying duration using quantitative diffusion and perfusion imaging. Stroke. 2007 Apr; 38(4):1336-44.
          View in: PubMed
        56. Fisher M, Hanley DF, Howard G, Jauch EC, Warach S. Recommendations from the STAIR V meeting on acute stroke trials, technology and outcomes. Stroke. 2007 Feb; 38(2):245-8.
          View in: PubMed
        57. Fisher M, Henninger N. Translational research in stroke: taking advances in the pathophysiology and treatment of stroke from the experimental setting to clinical trials. Curr Neurol Neurosci Rep. 2007 Jan; 7(1):35-41.
          View in: PubMed
        58. Bouley J, Fisher M, Henninger N. Comparison between coated vs. uncoated suture middle cerebral artery occlusion in the rat as assessed by perfusion/diffusion weighted imaging. Neurosci Lett. 2007 Feb 2; 412(3):185-90.
          View in: PubMed
        59. Fisher M. Is penumbral imaging useful for extending the treatment window for intravenous tissue plasminogen activator? Ann Neurol. 2006 Nov; 60(5):499-501.
          View in: PubMed
        60. Fisher M, Lees K, Papadakis M, Buchan AM. NXY-059: brain or vessel protection. Stroke. 2006 Aug; 37(8):2189-90.
          View in: PubMed
        61. Fisher M. Does neuroprotection with NXY-059 improve patient outcome after acute ischemic stroke? Nat Clin Pract Cardiovasc Med. 2006 Jun; 3(6):302-3.
          View in: PubMed
        62. Fisher M. The ischemic penumbra: a new opportunity for neuroprotection. Cerebrovasc Dis. 2006; 21 Suppl 2:64-70.
          View in: PubMed
        63. Padma V, Fisher M, Moonis M. Role of heparin and low-molecular-weight heparins in the management of acute ischemic stroke. Expert Rev Cardiovasc Ther. 2006 May; 4(3):405-15.
          View in: PubMed
        64. Henninger N, Sicard KM, Schmidt KF, Bardutzky J, Fisher M. Comparison of ischemic lesion evolution in embolic versus mechanical middle cerebral artery occlusion in Sprague Dawley rats using diffusion and perfusion imaging. Stroke. 2006 May; 37(5):1283-7.
          View in: PubMed
        65. Fisher M. Results of the management of atherothrombosis with clopidogrel in high-risk patients trial: implications for the neurologist. Arch Neurol. 2006 Jan; 63(1):20-4.
          View in: PubMed
        66. Henninger N, Fisher M. Normobaric hyperoxia - a promising approach to expand the time window for acute stroke treatment. Cerebrovasc Dis. 2006; 21(1-2):134-6.
          View in: PubMed
        67. Warach S, Kaufman D, Chiu D, Devlin T, Luby M, Rashid A, Clayton L, Kaste M, Lees KR, Sacco R, Fisher M. Effect of the Glycine Antagonist Gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: The GAIN MRI Substudy. Cerebrovasc Dis. 2006; 21(1-2):106-11.
          View in: PubMed
        68. Fisher M. Developing and implementing future stroke therapies: the potential of telemedicine. Ann Neurol. 2005 Nov; 58(5):666-71.
          View in: PubMed
        69. Shen Q, Ren H, Cheng H, Fisher M, Duong TQ. Functional, perfusion and diffusion MRI of acute focal ischemic brain injury. J Cereb Blood Flow Metab. 2005 Oct; 25(10):1265-79.
          View in: PubMed
        70. Shen Q, Ren H, Fisher M, Duong TQ. Statistical prediction of tissue fate in acute ischemic brain injury. J Cereb Blood Flow Metab. 2005 Oct; 25(10):1336-45.
          View in: PubMed
        71. Fisher M, Tatlisumak T. Use of animal models has not contributed to development of acute stroke therapies: con. Stroke. 2005 Oct; 36(10):2324-5.
          View in: PubMed
        72. Bardutzky J, Meng X, Bouley J, Duong TQ, Ratan R, Fisher M. Effects of intravenous dimethyl sulfoxide on ischemia evolution in a rat permanent occlusion model. J Cereb Blood Flow Metab. 2005 Aug; 25(8):968-77.
          View in: PubMed
        73. Bardutzky J, Shen Q, Henninger N, Bouley J, Duong TQ, Fisher M. Differences in ischemic lesion evolution in different rat strains using diffusion and perfusion imaging. Stroke. 2005 Sep; 36(9):2000-5.
          View in: PubMed
        74. Bardutzky J, Shen Q, Bouley J, Sotak CH, Duong TQ, Fisher M. Perfusion and diffusion imaging in acute focal cerebral ischemia: temporal vs. spatial resolution. Brain Res. 2005 May 10; 1043(1-2):155-62.
          View in: PubMed
        75. Moonis M, Kane K, Schwiderski U, Sandage BW, Fisher M. HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke. 2005 Jun; 36(6):1298-300.
          View in: PubMed
        76. Henning EC, Meng X, Fisher M, Sotak CH. Visualization of cortical spreading depression using manganese-enhanced magnetic resonance imaging. Magn Reson Med. 2005 Apr; 53(4):851-7.
          View in: PubMed
        77. Padma V, Fisher M, Moonis M. Thrombolytic therapy for acute ischemic stroke: 3 h and beyond. Expert Rev Neurother. 2005 Mar; 5(2):223-33.
          View in: PubMed
        78. Furlan AJ, Fisher M. Devices, drugs, and the Food and Drug Administration: increasing implications for ischemic stroke. Stroke. 2005 Feb; 36(2):398-9.
          View in: PubMed
        79. Ren H, Shen Q, Bardutzky J, Fisher M, Duong TQ. Partial-volume effect on ischemic tissue-fate delineation using quantitative perfusion and diffusion imaging on a rat stroke model. Magn Reson Med. 2004 Dec; 52(6):1328-35.
          View in: PubMed
        80. Padma V, Fisher M, Moonis M. Antihypertensive medications for risk reduction of first and recurrent ischemic stroke. Expert Rev Cardiovasc Ther. 2004 Nov; 2(6):867-76.
          View in: PubMed
        81. Fisher M, Davalos A. The MATCH study results in the context of secondary stroke prevention. Stroke. 2004 Nov; 35(11):2609.
          View in: PubMed
        82. Gerriets T, Stolz E, Walberer M, Müller C, Rottger C, Kluge A, Kaps M, Fisher M, Bachmann G. Complications and pitfalls in rat stroke models for middle cerebral artery occlusion: a comparison between the suture and the macrosphere model using magnetic resonance angiography. Stroke. 2004 Oct; 35(10):2372-7.
          View in: PubMed
        83. Shen Q, Ren H, Fisher M, Bouley J, Duong TQ. Dynamic tracking of acute ischemic tissue fates using improved unsupervised ISODATA analysis of high-resolution quantitative perfusion and diffusion data. J Cereb Blood Flow Metab. 2004 Aug; 24(8):887-97.
          View in: PubMed
        84. Duong TQ, Fisher M. Applications of diffusion/perfusion magnetic resonance imaging in experimental and clinical aspects of stroke. Curr Atheroscler Rep. 2004 Jul; 6(4):267-73.
          View in: PubMed
        85. Mayzel-Oreg O, Omae T, Kazemi M, Li F, Fisher M, Cohen Y, Sotak CH. Microsphere-induced embolic stroke: an MRI study. Magn Reson Med. 2004 Jun; 51(6):1232-8.
          View in: PubMed
        86. Gerriets T, Stolz E, Walberer M, Müller C, Kluge A, Kaps M, Fisher M, Bachmann G. Middle cerebral artery occlusion during MR-imaging: investigation of the hyperacute phase of stroke using a new in-bore occlusion model in rats. Brain Res Brain Res Protoc. 2004 Feb; 12(3):137-43.
          View in: PubMed
        87. Meng X, Fisher M, Shen Q, Sotak CH, Duong TQ. Characterizing the diffusion/perfusion mismatch in experimental focal cerebral ischemia. Ann Neurol. 2004 Feb; 55(2):207-12.
          View in: PubMed
        88. Moonis M, Fisher M. Antiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of use. Expert Rev Cardiovasc Ther. 2003 Nov; 1(4):611-5.
          View in: PubMed
        89. Fisher M. Stem cell transplantation for stroke: does it work, and if so, how? Stroke. 2003 Aug; 34(8):2083.
          View in: PubMed
        90. Fisher M. Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3. Stroke. 2003 Jun; 34(6):1539-46.
          View in: PubMed
        91. Shashoua VE, Adams DS, Boyer-Boiteau A, Cornell-Bell A, Li F, Fisher M. Neuroprotective effects of a new synthetic peptide, CMX-9236, in in vitro and in vivo models of cerebral ischemia. Brain Res. 2003 Feb 14; 963(1-2):214-23.
          View in: PubMed
        92. Fisher M, Brott TG. Emerging therapies for acute ischemic stroke: new therapies on trial. Stroke. 2003 Feb; 34(2):359-61.
          View in: PubMed
        93. Fisher M. Ongoing trials and future directions for acute ischemic stroke treatment. Adv Neurol. 2003; 92:401-8.
          View in: PubMed
        94. Fisher M, Ratan R. New perspectives on developing acute stroke therapy. Ann Neurol. 2003 Jan; 53(1):10-20.
          View in: PubMed
        95. Silva MD, Omae T, Helmer KG, Li F, Fisher M, Sotak CH. Separating changes in the intra- and extracellular water apparent diffusion coefficient following focal cerebral ischemia in the rat brain. Magn Reson Med. 2002 Nov; 48(5):826-37.
          View in: PubMed
        96. Moonis M, Fisher M. Considering the role of heparin and low-molecular-weight heparins in acute ischemic stroke. Stroke. 2002 Jul; 33(7):1927-33.
          View in: PubMed
        97. Li F, Liu KF, Silva MD, Meng X, Gerriets T, Helmer KG, Fenstermacher JD, Sotak CH, Fisher M. Acute postischemic renormalization of the apparent diffusion coefficient of water is not associated with reversal of astrocytic swelling and neuronal shrinkage in rats. AJNR Am J Neuroradiol. 2002 Feb; 23(2):180-8.
          View in: PubMed
        For assistance with using Profiles, please refer to the online tutorials or contact UMMS Help Desk or call 508-856-8643.
        Marc's Networks
        Click the "See All" links for more information and interactive visualizations!
        Concepts
        _
        Co-Authors
        _
        Similar People
        _
        Same Department
        Physical Neighbors
        _

        This is an official Page/Publication of the University of Massachusetts Worcester Campus
        Office of the Vice Provost for Research, 55 Lake Ave North, Worcester, Massachusetts 01655
        Questions or Comments? Email: publicaffairs@umassmed.edu Phone: 508-856-1572